Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBeta Bionics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | -$0.59 | -$0.28 | -$0.48 |
| Q2 2025 | 7 | -$0.69 | -$0.34 | -$0.46 |
| Q3 2025 | 5 | -$0.44 | -$0.40 | -$0.42 |
| Q4 2025 | 5 | -$0.55 | -$0.35 | -$0.39 |
| Q1 2026 | 4 | -$0.50 | -$0.39 | -$0.46 |
| Q2 2026 | 1 | -$0.48 | -$0.40 | -$0.44 |
| Q3 2026 | 1 | -$0.44 | -$0.37 | -$0.40 |
| Q4 2026 | 1 | -$0.45 | -$0.38 | -$0.41 |
| Q1 2027 | 1 | -$0.47 | -$0.39 | -$0.43 |
| Q2 2027 | 1 | -$0.41 | -$0.35 | -$0.38 |
| Q3 2027 | 1 | -$0.37 | -$0.31 | -$0.34 |
| Q4 2027 | 1 | -$0.39 | -$0.32 | -$0.36 |
| Q1 2028 | 2 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 2 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 2 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 2 | $0.00 | $0.00 | $0.00 |
Beta Bionics, Inc. Earnings Date And Information
Beta Bionics, Inc. last posted its earnings results on Tuesday, October 28th, 2025. The company reported $-0.33 earnings per share for the quarter, topping analysts' consensus estimates of $-0.45 by $0.12. The company had revenue of 27.25 M for the quarter and had revenue of 65.12 M for the year. Beta Bionics, Inc. has generated $-9 earnings per share over the last year ($-8.6 diluted earnings per share) and currently has a price-to-earnings ratio of -16.82. Beta Bionics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 24th, 2026 based on prior year's report dates.
Beta Bionics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/28/2025 | Q3 2025 | -$0.45 | -$0.33 | 0.12 | $23.97 M | $27.25 M |
| 07/29/2025 | Q2 2025 | -$0.51 | -$0.39 | 0.12 | $19.69 M | $23.24 M |
| 05/06/2025 | Q1 2025 | -$0.51 | -$0.93 | -0.42 | N/A | $17.64 M |
| 03/25/2025 | Q4 2024 | -$0.42 | -$0.42 | 0 | N/A | $20.44 M |
| 09/30/2024 | Q3 2024 | N/A | -$1.55 | N/A | N/A | $16.71 M |
| 06/29/2024 | Q2 2024 | N/A | -$0.33 | N/A | N/A | $15.05 M |
| 03/31/2024 | Q1 2024 | N/A | -$0.41 | N/A | N/A | $12.93 M |
| 12/31/2023 | Q4 2023 | N/A | -$3.13 | N/A | N/A | $8.35 M |
| 09/30/2023 | Q3 2023 | N/A | -$1.71 | N/A | N/A | $3.09 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Beta Bionics, Inc. Earnings: FAQ's
Beta Bionics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 24th, 2026 based offlast year's report dates.
In the previous quarter, Beta Bionics, Inc. (:BBNX) reported $-0.33 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.45 by $0.12.
The conference call for Beta Bionics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Beta Bionics, Inc.'s latest earnings report can be read online.
Beta Bionics, Inc. (:BBNX) has a recorded annual revenue of $65.12 M.
Beta Bionics, Inc. (:BBNX) has a recorded net income of $-54,756,000.Beta Bionics, Inc. has generated $-8.6 earnings per share over the last four quarters.
Beta Bionics, Inc. (:BBNX) has a price-to-earnings ratio of -16.82 and price/earnings-to-growth ratio is -0.45.